MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference

 MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR),

a commercial-stage biopharmaceutical company and a leader in antibody, 
protein and peptide technologies, announced today that Jean-Paul Kress, 
M.D., Chief Executive Officer of MorphoSys, will present at the 39th Annual 
J.P. Morgan Healthcare Conference on Wednesday January 13 at 2:50 p.m. EST. 
 
Live audio of the presentation can be accessed from the Media and Investors 
section under Conferences on MorphoSys' website, www.morphosys.com. The 
presentation as well as a replay of the webcast will also be available on 
MorphoSys' website. 

https://www.marketscreener.com/quote/stock/MORPHOSYS-AG-436425/news/PRESS-RELEASE-MorphoSys-To-Present-At-the-39th-Annual-J-P-Morgan-Healthcare-Conference-32165357/